AUG 20, 2020 9:11 PM PDT

Machines Learn the Difference Between Autism and Schizophrenia

WRITTEN BY: Tara Fernandez

Autism spectrum disorder and schizophrenia — one is a developmental disorder affecting communication and behavior, while the other causes those affected to interpret reality abnormally. Though seemingly completely different conditions, neuroscientists have, for a long time, suspected a strong link between them. Not only do some of the presentations of these disorders overlap, but autism spectrum disorder patients are 10 times more likely to develop schizophrenia than those from the general population. 

The clinical challenge is that most of the diagnostic procedures for psychiatric conditions are largely subjective and rely on psychiatrists picking up on sometimes extremely subtle behavioral cues to make a definitive diagnosis. Researchers at the University of Tokyo believe that a powerful combo of next-generation brain imaging technologies and machine learning could be the key to radically transforming mental health care as we know it.

In a recent study published in Translational Psychiatry, Shinsuke Koike and colleagues designed machine learning algorithms, training them to interpret magnetic resonance imaging (MRI) brain scans from over 200 adults who had been diagnosed with an autism spectrum disorder, schizophrenia or both. They also included a cohort of neurotypical people who did not experience any mental health concerns. During this “training” phase, the algorithm scanned the images, looking for variability in the thickness, surface area, or volume of various brain regions.

 

 

To test out the algorithm’s capabilities, the researchers presented it with an additional 43 patient scans with almost unbelievable outcomes: the machine’s diagnoses matched the psychiatric assessment with up to 85 percent accuracy. The biggest breakthrough was the ability of the machine learning platform to tell the difference between the different categories of patients in the study, even picking up those who were just determined to have schizophrenia risk factors.

Though there are several published studies exploring the potential of artificial intelligence to assist with clinical diagnostics (all with varying levels of success) Koike believes the accuracy of the teams' newly-developed algorithm lies in the “clean” data used during the learning phase — all images were taken on a single MRI machine.

“If you take a photo with an iPhone or Android camera phone, the images will be slightly different. MRI machines are also like this - each MRI takes slightly different images, so when designing new machine learning protocols like ours, we use the same MRI machine and the exact same MRI procedure,” said Koike.

 

Sources: Translational Psychiatry, University of Tokyo.


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
APR 14, 2021
Clinical & Molecular DX
AI-Powered Imaging System Can Tell If a Patient Is Cancer-Free
APR 14, 2021
AI-Powered Imaging System Can Tell If a Patient Is Cancer-Free
A patient undergoes chemotherapy and radiation for rectal cancer. How do doctors know whether all the malignant tissue h ...
MAY 06, 2021
Clinical & Molecular DX
Using Biology as Technology: A Paradigm Shift
MAY 06, 2021
Using Biology as Technology: A Paradigm Shift
Digital networks have changed the world by integrating into almost every aspect of our lives, but they have yet to direc ...
MAY 06, 2021
Clinical & Molecular DX
Sweat Sensor Can Tell If a Storm's Coming
MAY 06, 2021
Sweat Sensor Can Tell If a Storm's Coming
A surge of pro-inflammatory cytokines, intense, and sustained inflammation leading to organ damage and a high risk of de ...
JUN 04, 2021
Cannabis Sciences
Neurotechnology and Saliva Tests Detect Psychoactive Effects of Cannabis
JUN 04, 2021
Neurotechnology and Saliva Tests Detect Psychoactive Effects of Cannabis
Researchers from contract research organization, KGK Science, working on behalf of neurotechnology firm Zentrela, have f ...
JUN 24, 2021
Clinical & Molecular DX
Test Lets Cancer Patients Track Whether Their Treatment Is Working in Real Time
JUN 24, 2021
Test Lets Cancer Patients Track Whether Their Treatment Is Working in Real Time
Researchers from Singapore have created the ExoSCOPE, the world’s first blood test for tracking whether or not a p ...
AUG 31, 2021
Clinical & Molecular DX
How Quickly Will Alzheimer's Progress? Inflammatory Proteins Have the Answers.
AUG 31, 2021
How Quickly Will Alzheimer's Progress? Inflammatory Proteins Have the Answers.
Alzheimer's is a neurodegenerative disease that affects over 26 million worldwide and is associated with memory prob ...
Loading Comments...